MEDICINA LEGATIS: what changed
MEDICINA LEGATIS
Largest movements
- Stocks and contracts +€17,520
up €17,520 (+153%), from €11,455 to €28,975
- Cash +€8,146
up €8,146 (+899%), from €906 to €9,052
mainly Trade debts (+€31,321) and Net result for the year (+€10,983)
- Receivables within one year +€5,969
up €5,969 (+62.4%), from €9,572 to €15,541
of which Trade receivables: +€5,626
- Intangible fixed assets -€1,134
down €1,134 (-20.7%), from €5,468 to €4,334
- Deferred charges and accrued income +€810
new in 2025: €810
- Trade debts +€31,321
up €31,321 (+198%), from €15,848 to €47,169
of which Bills of exchange payable: +€42,562
- Profit (loss) carried forward +€10,983
up €10,983 (+34.6%), from -€31,699 to -€20,716
- Tax, wage and social debts -€10,338
down €10,338 (-91.9%), from €11,250 to €912
of which Remuneration and social security: -€11,250
- Turnover +€170,012
new in 2025: €170,012
- Gross operating margin +€44,275
up €44,275, from -€27,258 to €17,017
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €29,399 | €61,365 | +€31,966 | +109% |
| Fixed assets | 21/28 | €7,466 | €6,987 | -€479 | -6.4% |
| Intangible fixed assets | 21 | €5,468 | €4,334 | -€1,134 | -20.7% |
| Tangible fixed assets | 22/27 | €1,998 | €2,653 | +€655 | +32.8% |
| Plant, machinery and equipment | 23 | €1,998 | €2,653 | +€655 | +32.8% |
| Current assets | 29/58 | €21,933 | €54,378 | +€32,445 | +148% |
| Stocks and contracts in progress | 3 | €11,455 | €28,975 | +€17,520 | +153% |
| Stocks | 30/36 | €11,455 | €28,975 | +€17,520 | +153% |
| Amounts receivable within one year | 40/41 | €9,572 | €15,541 | +€5,969 | +62.4% |
| Trade receivables | 40 | €8,663 | €14,289 | +€5,626 | +64.9% |
| Other amounts receivable | 41 | €909 | €1,252 | +€343 | +37.7% |
| Cash at bank and in hand | 54/58 | €906 | €9,052 | +€8,146 | +899% |
| Deferred charges and accrued income | 490/1 | - | €810 | +€810 | |
| Total equity and liabilities | 10/49 | €29,399 | €61,365 | +€31,966 | +109% |
| Equity | 10/15 | -€23,699 | -€12,716 | +€10,983 | +46.3% |
| Contributions | 10/11 | €8,000 | €8,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€31,699 | -€20,716 | +€10,983 | +34.6% |
| Amounts payable | 17/49 | €53,098 | €74,081 | +€20,983 | +39.5% |
| Amounts payable within one year | 42/48 | €53,098 | €74,081 | +€20,983 | +39.5% |
| Trade debts | 44 | €15,848 | €47,169 | +€31,321 | +198% |
| Suppliers | 440/4 | €15,848 | €4,607 | -€11,241 | -70.9% |
| Bills of exchange payable | 441 | - | €42,562 | +€42,562 | |
| Taxes, remuneration and social security | 45 | €11,250 | €912 | -€10,338 | -91.9% |
| Taxes | 450/3 | - | €912 | +€912 | |
| Remuneration and social security | 454/9 | €11,250 | - | -€11,250 | |
| Other amounts payable | 47/48 | €26,000 | €26,000 | = | 0.0% |
| Turnover | 70 | - | €170,012 | +€170,012 | |
| Non-recurring operating income | 76A | - | €10,800 | +€10,800 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,672 | €2,979 | +€1,307 | +78.2% |
| Other operating charges | 640/8 | €823 | €946 | +€123 | +14.9% |
| Gross operating margin | 9900 | -€27,258 | €17,017 | +€44,275 | |
| Operating profit (loss) | 9901 | -€29,753 | €13,092 | +€42,845 | |
| Financial charges | 65/66B | €478 | €2,109 | +€1,631 | +341% |
| Recurring financial charges | 65 | €478 | €2,109 | +€1,631 | +341% |
| Profit (loss) for the period before taxes | 9903 | -€30,231 | €10,983 | +€41,214 | |
| Profit (loss) for the period | 9904 | -€30,231 | €10,983 | +€41,214 | |
| Profit (loss) for the period to be appropriated | 9905 | -€30,231 | €10,983 | +€41,214 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 4 November 2026 via checked.be.